Abstract:Epigallocatechin gallate (EGCG), the primary catechin in green tea, has improved cholesterol metabolism. However, the molecular mechanisms of EGCG underlying these functions are not fully understood. In this study, we aimed to investigate the molecular mechanisms underlying EGCG's effect on low-density lipoprotein (LDL) in HepG2 cells. Real-time PCR and Western blot analysis were used to determine the mRNA and protein levels in the human hepatoma cell line (HepG2). LDL uptake assay was used to quantify the low-density lipoprotein receptor (LDLR) function. EGCG induced significantly up-regulated LDLR protein and mRNA levels in HepG2 cells ( P < 0.05). Both at the transcriptional level and at the protein level, EGCG can significantly ( P < 0.05) down-regulate the elevated expression levels of liver X receptor α (LXRα) and inducible degrader of the LDLR (Idol) due to 25-OHC. Fluorescence results showed that EGCG induction could also significantly increase LDL uptake ( P < 0.05). EGCG regulates LDL uptake through the LXRα-LDLR pathway, and EGCG can effectively improve the abnormal expression of protein and mRNA induced by 25-OHC.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the effects of epigallocatechin - 3 - gallate (EGCG) on the expression of low - density lipoprotein receptor (LDLR) and inducible degrader (Idol) and its molecular mechanisms. Specifically, the study aims to clarify how EGCG regulates the expression of LDLR and Idol in HepG2 cells, thereby providing a theoretical basis for the development of EGCG as a new drug for the treatment of atherosclerotic cardiovascular diseases (ASCVD). ### Research Background - **Atherosclerotic cardiovascular diseases (ASCVD)** are the leading cause of human death, and excessive low - density lipoprotein cholesterol (LDL - c) is the most important risk factor. - **Low - density lipoprotein receptor (LDLR)** is a cell - surface receptor mainly expressed in the liver and clears LDL particles in the blood through receptor - mediated endocytosis. Insufficient LDLR function can lead to an increase in the plasma LDL - c concentration, thereby accelerating the process of atherosclerosis. - **EGCG** is the main catechin in green tea and has been proven to improve cholesterol metabolism, but its specific molecular mechanism is not yet fully understood. ### Research Objectives - **To explore the molecular mechanisms of EGCG on the expression of LDLR and Idol in HepG2 cells**: - Detect the mRNA and protein levels of LDLR and Idol in HepG2 cells after EGCG treatment by real - time PCR and Western blot analysis. - Evaluate the effect of EGCG on LDLR function through low - density lipoprotein (LDL) uptake experiments. - Explore whether EGCG can improve the abnormal protein and mRNA expression caused by 25 - hydroxy cholesterol (25 - OHC) by regulating the LXRα - LDLR pathway. ### Main Findings - **EGCG significantly up - regulated the mRNA and protein levels of LDLR in HepG2 cells** (P < 0.05). - **EGCG significantly down - regulated the high expression of LXRα and Idol caused by 25 - OHC** (P < 0.05), indicating that EGCG can reduce the expression of Idol by inhibiting the activation of LXRα. - **EGCG significantly increased the LDL uptake ability of HepG2 cells** (P < 0.05), and this effect was still significant in the presence of 25 - OHC. ### Conclusions - **EGCG regulates the expression and function of LDLR through the LXRα - LDLR pathway** and can effectively improve the abnormal protein and mRNA expression caused by 25 - OHC. - These findings provide theoretical support for EGCG as a potential drug for the treatment of ASCVD, but further animal experiments are still needed to verify its in - vivo effects and mechanisms. ### Future Directions - **Conduct animal experiments** to further verify the effect of EGCG on the LXRα - LDLR pathway in vivo. - **Explore the interaction between EGCG and the LXRα - LDLR axis in liver cancer**. - **Clarify the specific action sites of EGCG in the LXRα - LDLR pathway** in order to understand its molecular mechanism more in - depth.

Epigallocatechin gallate induces an up-regulation of LDLR accompanied by a reduction of idol in Hepg2 cells

Effects of Epi-Gallocatechin Gallate on PC-3 Cell Cytoplasmic Membrane in the Presence of Cu2+

Down-regulation of Connexin43 Gap Junction by Serum Deprivation in Human Endothelial Cells Was Improved by (−)-Epigallocatechin Gallate Via ERK MAP Kinase Pathway

Proteomic Analysis of the Inhibitory Effect of Epigallocatechin Gallate on Lipid Accumulation in Human HepG2 Cells

(-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B

(-)-Epicatechin gallate blocked cellular foam formation in atherosclerosis by modulating CD36 expression in vitro and in vivo

Inhibitory Effect and Mechanism of Epigallocatechin Gallate on the Differentiation of 3T3-L1 Preadipocytes

Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1/FOXO1 signaling pathway

(-)-Epigallocatechin-3-gallate Induces Non-Apoptotic Cell Death in Human Cancer Cells Via Ros-Mediated Lysosomal Membrane Permeabilization

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer

Epigallocatechin Gallate-Β-lactoglobulin Nanoparticles Improve the Antitumor Activity of EGCG for Inducing Cancer Cell Apoptosis

Epigallocatechin-3-gallate Ameliorates LPS-induced Inflammation by Inhibiting the Phosphorylation of Akt and ERK Signaling Molecules in Rat H9c2 Cells

[Epigallocatechin Gallate Attenuates the Expression of Regulated Upon Activation Normal T Cell Expressed and Secreted Induced by Lipopolysaccharide in Human Retinal Endothelial Cells].

A New Molecular Mechanism Underlying the EGCG-mediated Autophagic Modulation of AFP in HepG2 Cells

EGCG suppressed activation of hepatic stellate cells by regulating the PLCE1/IP3/Ca2+ pathway

Epigallocatechin-3-gallate Attenuates Lipopolysaccharide-Induced Inflammation in Human Retinal Endothelial Cells

Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT

The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1

Green Tea Polyphenol EGCG Alleviates Metabolic Abnormality and Fatty Liver by Decreasing Bile Acid and Lipid Absorption in Mice

Epigallocatechin Gallate Induces Chemopreventive Effects on Rats with Diethylnitrosamine‑induced Liver Cancer Via Inhibition of Cell Division Cycle 25A.

EGCG Attenuates Pro-Inflammatory Cytokines and Chemokines Production in LPS-stimulated L02 Hepatocyte